FDA Adverse Event Injury Summary report: N

TRULIANT TIB IMP PSC INSERT SZ 4, 9MM

MDR report key: 18725508 · Received February 16, 2024

Report

Report Number
1038671-2024-00249
Event Type
Injury
Date Received
February 16, 2024
Date of Event
December 21, 2018
Report Date
September 2, 2025
Manufacturer
EXACTECH, INC.
Product Code
JWH
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OK, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

(H3) PENDING EVALUATION (D10) CONCOMITANT DEVICE(S): 02-010-06-0340 - LOGIC CC FEMORAL SIZE 4, RIGHT 02-012-45-4040 - LGC TIBIAL FIT TRAY CEM SZ 4F / 4T 200-07-35 - ADVANCED PATELLA 35MM 3 PEG IMPLANT.

Additional Manufacturer Narrative · 0

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY CORRECTED INFORMATION: PLEASE DISREGARD THIS REPORT AS IT WAS SUBMITTED IN ERROR. EVENT WAS PREVIOUSLY REPORTED UNDER REPORT # 1038671-2024-00236.

Description of Event or Problem · 0

AS REPORTED BY THE EXACTECH TRULIANT KNEE CLINICAL STUDY, THE 62 YEAR OLD MALE PATIENT HAD AN INITIAL RIGHT TKA ON 13-NOV-2018 AND PRESENTED WITH INFECTION, 0 YEAR(S) AND 1 MONTH(S) POST INITIAL PROCEDURE ON (B)(6) 2018. 12-11-2018 MILD SWELLING, MODERATE PAIN; (B)(6) 2019: MODERATE SWELLING, ARTHROCENTESIS REVEALED +STAPHYLOCOCCUS PANEL. REVISION SCHEDULE (B)(6) 2019. REFERRED TO ID. IV ABX THERAPY X 6 WEEKS. REVISION SCHEDULED (B)(6) 2019. THE CASE REPORT FORM INDICATES THAT THIS EVENT IS UNLIKELY RELATED TO THE DEVICE AND DEFINITELY RELATED TO THE PROCEDURE. THE REPORT ALSO INDICATES THAT THE ACTION TAKEN WAS REVISION ON (B)(6) 2019. THE OUTCOME IS REPORTED AS RESOLVED ON (B)(6) 2019. NO DEVICE RETURN ANTICIPATED DUE TO BEING A CLINICAL TRIAL STUDY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
389197 TRULIANT TIB IMP PSC INSERT SZ 4, 9MM PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL JWH EXACTECH, INC.

Patients

Seq Age Sex Outcome Treatment
1 62 YR Male SEE H10.